Honore Tage

Director at VNDA

Sold, on record
$241k
Dollars the filings state
Form 4 sales
1
Latest Feb 23, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • VNDAVanda Pharmaceuticals Inc.Director

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice VNDANotice
    Feb 23, 2026 2026

    Filed to sell 30,000 shares ($241k)

    Honore Tage, Director

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale VNDANo plan
    Feb 23, 2026 same day

    Sold 30,000 shares at $8.03 ($241k)

    Honore Tage, Director

    No 10b5-1 planSold 24.3% of holdings ($991k position)93,469 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Honore Tage
Source
Feb 23, 2026Feb 24, 2026VNDADirectorForm 4 sale30,000$241k24.3%No planSEC
Feb 23, 2026Feb 23, 2026VNDADirectorForm 144 notice30,000$241kNoticeSEC